project id: TCGA-UCEC; case submitter id: TCGA-AX-A2HK; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.0; rna integrity number: 7.5; spectrophotometer method: UV Spec; age at index: 77; days to birth: -28316; days to death: 90; ethnicity: not reported; gender: female; race: white; vital status: Dead; year of birth: 1928; year of death: 2005; age at diagnosis: 28316; classification of tumor: not reported; days to diagnosis: 0; figo stage: Stage IIIC; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2005; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2045; initial weight: 240.0; oct embedded: false; preservation method: Unknown; sample id: ebe937b7-b2bf-45b9-8517-009e6f67b6de; sample submitter id: TCGA-AX-A2HK-01A; portion id: be2653dd-c013-4d02-bf20-7b07b37d66fb; portion submitter id: TCGA-AX-A2HK-01A-11; slide id: db601690-3f5a-4087-a921-f599914fdda6; slide submitter id: TCGA-AX-A2HK-01A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 18.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 2.0; percent tumor cells: 88.0; percent tumor nuclei: 96.0; section location: TOP;